1-Bromo-3-benzyloxy-4,5-difluorobenzene, 97.0%, 2g

8-BROMO-3-CHLORO-[1,2,4]TRIAZOLO[4,3-A]PYRIDINE, 95.0%, 1g

N-(6-Chloro-4-trifluoromethyl-pyridin-2-yl)-N'-[1-(2,5-dimethoxy-phenyl)-meth-(E)-ylidene]-hydrazine, 95.0%, 100mg

(S)-2-Amino-3-(2,5-dichlorophenyl)propanoic acid, 95.0%, 5g

3-(3-Fluorophenyl)-[1,2,4]triazolo[4,3-a]pyridine-6-carboxylic acid, 1g

3-Iodo-6-methyl-1H-pyrrolo[2,3-b]pyridine, 95.0%, 5g

2-Hydroxy-1,2-bis(4-methoxyphenyl)ethanone, 95.0%, 25g

3-(((BENZYLOXY)CARBONYL)AMINO)OXETANE-3-CARBOXYLIC ACID, 95.0%, 500mg

3-(Aminomethyl)-4-methoxy-6-methylpyridin-2(1H)-one hydrochloride, 98%, 100mg

1-Bromo-2-nitrobenzene, 98.0%, 25g

2-Fluoro-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 250mg

Microliter syringe MICROLITER® series 7000 Point type 2, 5.0 µl, 7105 KH, 1 piece

3,5-Diphenylpyrazole>98.0%(GC)25g